Sodium Thiosulfate Injection USP 250 mg

Sodium Thiosulfate Injection USP 250 MG is a sterile solution used for various medical purposes. This intravenous solution is manufactured by Pfizer Canada ULC and is commonly used in clinical settings.

Sodium Thiosulfate Injection is primarily used as an antidote for cyanide poisoning. It works by converting cyanide into less toxic compounds that can be easily excreted by the body. Additionally, it may be used in other medical contexts where its properties are beneficial, such as in the treatment of certain heavy metal poisonings. The specific uses of Sodium Thiosulfate Injection can vary depending on the clinical situation and the prescribing healthcare provider's instructions.

When administered intravenously, Sodium Thiosulfate Injection works by binding to cyanide and other toxins, facilitating their removal from the body. This process helps to reduce the toxic effects of these substances. The effects of Sodium Thiosulfate Injection are typically observed within a short period after administration, providing rapid relief in emergency situations.

Sodium Thiosulfate Injection should be handled with care and administered by healthcare professionals. It is important to follow proper storage and handling guidelines to maintain its efficacy. Patients should be monitored closely after administration to ensure there are no adverse reactions. Always consult a healthcare provider for specific precautions and contraindications.

Sodium Thiosulfate Injection may interact with other medications or substances. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Certain medications, such as those that affect kidney function, may require careful monitoring when used concurrently with Sodium Thiosulfate Injection.